2: FOLFIRI left side
3: Pmab + FOLFIRI right side
1: Pmab + FOLFIRI left side
Panitumumab outcome by tumour location analysis
Study 181: OS
•
Boeckx N, et al. Ann Oncol 2016;27(Suppl 6):abstract 89P (and poster).
48
44
40
36
32
28
24
20
16
12
8
4
0
0
20
40
60
80
100
Kaplan–Meier estimate
0
1
0
5
6
0
1
12
17
2
1
18
25
2
3
38
33
2
4
48
43
4
4
72
59
4
5
87
71
7
7
106
92
11
13
123
110
18
20
141
132
24
29
150
148
31
39
1:
2:
3:
4:
No. of subjects
4: FOLFIRI right side
Months
Median OS, months
Pmab + FOLFIRI
FOLFIRI
HR (95% CI)
Left
20.1
16.6
0.96 (0.74‒1.23)
Right
10.3
8.1
1.14 (0.68‒1.89)
WT
RAS
